High-grade intraductal carcinoma of the parotid gland harboring CTNNA1::ALK rearrangement: Changes in genetic status using genetic testing during treatment with an ALK inhibitor.

Takane WatanabeYoshitaka HonmaKan YonemoriKuniko SunamiSeiichi YoshimotoTaisuke Mori

Published in: Head & neck (2023)

The clinical course suggested the concurrent emergence of TP53 and PIK3CA mutations and ALK-TKI drug-selective growth of non-ALK rearrangement gene tumor cells.

Keyphrases

advanced non small cell lung cancer
high grade
epidermal growth factor receptor
genome wide
copy number
low grade
dna methylation
emergency department
adverse drug